Tin-Yun Tang Katherine Daunov Richard T Lee
10.3389/fonc.2021.780798
Front Oncol
2021 Dec 16;11:780798.
cabozantinib hepatocellular carcinoma (hcc) low dose minimal effective dose regorafenib sorafenib
CC BY
https://pubmed.ncbi.nlm.nih.gov/34976819/
Case Reports
PMC8716780
34976819
Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma
2021